Customized Genetic Testing Market Report 2026

Customized Genetic Testing Market Overview

• Customized Genetic Testing market size has reached to $14.13 billion in 2025 • Expected to grow to $29.5 billion in 2030 at a compound annual growth rate (CAGR) of 15.8% • Growth Driver: Rising Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Demand For Tailored Therapies And Preventive Healthcare • Market Trend: Advancements In Direct-To-Consumer Genetic Testing Solutions • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Customized Genetic Testing Market?

Customized genetic testing is a personalized approach to genetic analysis that tailors the selection of genes, variants, or DNA regions examined based on an individual’s unique needs, such as their medical history, family health background, ethnicity, or specific clinical concerns. This testing focuses on genes most relevant to the patient’s situation, allowing for more precise risk assessment, diagnosis, and management. Customized genetic testing approach helps identify inherited conditions, guide treatment choices, and support decisions in areas such as disease prevention, reproductive planning, and personalized medicine. The main test types of customized genetic testing are predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, and pharmacogenomic testing. Predictive Testing involves analyzing an individual's genetic makeup to assess the risk of developing certain hereditary conditions before symptoms appear. It is particularly useful for conditions that manifest later in life, allowing for early interventions and informed decision-making. The sample involved are saliva, blood, and buccal swab, which are tested with next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray analysis, and single-cell sequencing technologies. The various applications involved are oncology, cardiovascular diseases, neurological disorders, metabolic disorders, which are used for predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, and pharmacogenomic testing.

What Is The Customized Genetic Testing Market Growth Forecast?

The customized genetic testing market size is expected to see rapid growth in the next few years. It will grow to $29.5 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising integration of genomics in routine care, expansion of preventive healthcare strategies, growing adoption of precision oncology, increasing investment in genomic data platforms. Major trends in the forecast period include increasing adoption of personalized genetic panels, growing use of ngs-based customized testing, expansion of pharmacogenomic applications, rising demand for targeted risk assessment, enhanced integration of clinical decision support.

Global Customized Genetic Testing Market Segmentation

1) By Test Type: Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing 2) By Sample Type: Saliva, Blood, Buccal Swab 3) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray Analysis, Single-Cell Sequencing 4) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Metabolic Disorders 5) By End-User: Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing Subsegments: 1) By Predictive Testing: Cancer Susceptibility Testing, Neurodegenerative Disorder Testing, Cardiovascular Disease Risk Testing, Metabolic Disorder Risk Testing 2) By Carrier Testing: Cystic Fibrosis Carrier Testing, Sickle Cell Anemia Carrier Testing, Tay–Sachs Disease Carrier Testing, Thalassemia Carrier Testing 3) By Prenatal And Newborn Testing: Non-Invasive Prenatal Testing (NIPT), Newborn Screening Panels, Chorionic Villus Sampling (CVS), Amniocentesis-Based Genetic Testing 4) By Diagnostic Testing: Rare Disease Diagnosis, Oncology Genetic Testing, Neurological Disorder Diagnosis, Infectious Disease-Associated Genetic Testing 5) By Pharmacogenomic Testing: Drug Metabolism Testing, Oncology Pharmacogenomics, Cardiovascular Drug Response Testing, Psychiatric Drug Response Testing

What Is The Driver Of The Customized Genetic Testing Market?

The increasing adoption of personalized medicine is expected to propel the growth of the customized genetic testing market going forward. Personalized medicine refers to a medical approach in which treatments, prevention strategies, and healthcare decisions are tailored to the individual characteristics of each patient. The increasing adoption of personalized medicine is due to advances in genomics, proteomics, and biomarker discovery, which enable tailored treatments based on individual genetic profiles, driving demand for targeted therapies, improved diagnostics, and precision healthcare solutions. Customized genetic testing plays a critical role in this shift by providing detailed genetic insights that enable precise disease risk assessments, targeted therapies, and preventive care. For instance, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that in 2023, the United States Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, compared to just 6 approvals in 2022. Therefore, the increasing adoption of personalized medicine is driving the growth of the customized genetic testing industry.

Key Players In The Global Customized Genetic Testing Market

Major companies operating in the customized genetic testing market are Guardant Health, Tempus, Invitae, 23andMe, Labcorp, Quest Diagnostics, Revvity Omics (PerkinElmer Genomics), Natera, Myriad Genetics, BGI Genomics, CENTOGENE, Veracyte, Fulgent Genetics, LetsGetChecked, Helix, MedGenome, Baylor Genetics, Prenetics, Eurofins (Clinical Genetics), Mapmygenome, Nebula Genomics

Global Customized Genetic Testing Market Trends and Insights

Major companies operating in the customized genetic testing market are increasingly emphasizing direct-to-consumer solutions, particularly at-home DNA testing combined with tailored health plans derived from individual genetic profiles. At-home DNA testing is a type of genetic test that individuals can perform outside of a clinical setting, usually by ordering a kit online or from a pharmacy, collecting a saliva or cheek swab sample at home, and then mailing it to a laboratory for analysis. For instance, in May 2025, Hydreight Technologies Inc., a Canada-based digital health technology company, introduced a personalized genetic testing and wellness solution on its VSDHOne Platform. The service offers patients convenient access to at-home DNA testing kits and provides customized health plans addressing nutrition, fitness, supplementation, and medication compatibility. Additionally, the platform ensures continuity of care through integrated telehealth services and in-person consultations delivered by licensed healthcare professionals.

What Are Latest Mergers And Acquisitions In The Customized Genetic Testing Market?

In March 2025, Tempus, a U.S.-based precision medicine company, acquired Ambry Genetics for an undisclosed sum. The acquisition is intended to strengthen Tempus’ market position and broaden its technological capabilities in genomic testing by combining Ambry’s expertise in inherited disease diagnostics with Tempus’ AI-powered precision medicine platform. Ambry Genetics, a US-based company, is a leading provider of clinical genetic testing services, with a strong focus on inherited disease diagnostics, cancer risk evaluation, and next-generation sequencing solutions that support precision healthcare.

Regional Outlook

North America was the largest region in the customized genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Customized Genetic Testing Market?

The customized genetic testing market includes revenues earned by entities by providing services such as personalized testing, diagnostic evaluations, and customized genomic reporting. The market value also includes the worth of related goods supplied by service providers or bundled within their offerings. Only goods and services exchanged between entities or sold directly to end consumers are accounted for in this valuation.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Customized Genetic Testing Market Report 2026?

The customized genetic testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the customized genetic testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.